{ "article": { "format_version": 5, "presentation": "complete-card", "overview": "Medicare is federal health insurance, usually starting at 65. First confirm your enrollment deadline and the date coverage begins, including any exception for insurance through current employment. Then compare a complete Original Medicare arrangement with Medicare Advantage using your doctors, prescriptions, travel, and yearly costs. Keep Part B, Part D, and Medigap enrollment protections separate.", "sections": [ { "id": "understand-medicare", "role": "explanation", "title": "What Medicare covers and how the parts fit", "intro": "Turning 65 usually means making two decisions: when to enroll in Medicare and how to receive its benefits. Understanding the letters makes both decisions easier.", "items": [ { "label": "Start with hospital, medical, and prescription coverage", "text": "Medicare is federal health insurance for most people age 65 or older and for some younger people with qualifying disabilities or kidney disease. Part A helps pay for inpatient hospital care, qualifying skilled nursing care, hospice, and some home health care. Part B helps pay for doctors, outpatient care, equipment, and many preventive services. Part D helps pay for prescription drugs through a Medicare-approved private plan. The letters identify the type of coverage. Choosing an insurer is a separate decision.", "source_ids": [ "parts", "ssa-signup" ] }, { "label": "Compare two complete ways to receive Medicare", "text": "Original Medicare is Part A plus Part B, administered through the federal program. People may add a separate Part D plan and, when eligible, Medigap insurance to help with remaining medical costs. Medicare Advantage, or Part C, is a Medicare-approved private plan that delivers A and B benefits and usually includes D. You need both A and B to join Advantage and continue paying the Part B premium. Medigap supplements Original Medicare; it does not supplement Advantage. These are alternative coverage arrangements, not four plans everyone buys.", "source_ids": [ "compare", "drug-basics", "costs" ] }, { "label": "Read the cost words before comparing the price", "text": "A premium is the recurring price of having coverage. A deductible is an amount you pay before specified insurance benefits begin paying; a copayment is a fixed charge, while coinsurance is a percentage of a covered cost. CMS lists the standard Part B premium at $202.90 per month and the annual Part B deductible at $283 for 2026. Some people pay more because of income or penalties. A plan advertised with a zero additional premium can still require the Part B premium and substantial service costs. Keep the year beside every quoted amount.", "source_ids": [ "cms-2026", "costs", "drug-costs" ] } ] }, { "id": "enrollment-calendar", "role": "application", "title": "When to sign up and when coverage begins", "intro": "Permission to enroll and the first day insurance pays are different dates. Record both before existing coverage ends.", "items": [ { "label": "Use your birthday month to locate the first enrollment window", "text": "The usual age-65 Initial Enrollment Period, or IEP, has seven months: the three months before your birthday month, the birthday month, and the next three. Medicare.gov gives separate rules for people born on the first day of a month. For an ordinary October birthday, the usual window runs July through January; that example identifies the signup period, not seven months of active coverage. A younger person already eligible through disability or kidney disease follows another route. Use the official eligibility questions when your circumstances differ.\n\nTake an illustrative October 15 birthday for someone using the usual age-65 Initial Enrollment Period, with no special enrollment circumstance assumed. July through January is the signup window. For Part B, signing up in September ordinarily starts coverage in October; signing up in October ordinarily starts it in November. The last permissible signup month and the first covered month are therefore different pieces of information.\n\nNow add an existing policy ending September 30. The person needs to verify the effective date of the new coverage, not merely show that an application was submitted sometime within the seven-month window. They keep the actual enrollment notice and ask the official service to resolve a mismatch. First-of-month birthdays, current employment and other exceptions need their own checks. This example explains the calendar distinction; it does not choose coverage or determine an individual's eligibility.", "source_ids": [ "coverage-start", "signup-timing" ] }, { "label": "Confirm automatic enrollment from the actual notice", "text": "Some people already receiving Social Security or Railroad Retirement benefits get A and B automatically; others must apply. Medicare.gov's signup questions ask whether benefits began at least four months before age 65, and explain exceptions such as Part B enrollment in Puerto Rico or outside the United States. Read the welcome package and the effective dates on the card. If no notice arrives, establish the correct route through Social Security rather than assume your birthday did the paperwork. Choosing health coverage and claiming retirement benefits are connected administrative choices, but they are not the same decision.", "source_ids": [ "how-signup", "ssa-signup" ] }, { "label": "Match the first covered month to the end of existing insurance", "text": "For Part B and Part A that requires a premium, enrolling before the month you turn 65 generally starts coverage in that birthday month. Enrolling in the birthday month or the following three months generally starts it the next month. Medicare.gov says coverage starts on the first of a month, with a special first-of-month birthday rule. An application receipt is useful evidence of submission, but it is not a substitute for confirmation of the effective date. Keep the old policy's ending date alongside that confirmation and ask the agency to resolve a mismatch.", "source_ids": [ "coverage-start", "ssa-signup" ] }, { "label": "Use the appropriate recovery period if a deadline was missed", "text": "Medicare.gov describes a General Enrollment Period for Part B and premium Part A from January 1 through March 31, with coverage generally starting the next month. A penalty may apply. Special Enrollment Periods also exist for defined circumstances, including some losses of coverage, disasters, and misleading employer or health-plan information. They have their own conditions and deadlines; they are not automatic extensions for every late application. Bring notices and dates to Social Security or SHIP so the applicable route can be checked while time remains.", "source_ids": [ "coverage-start", "ship" ] } ] }, { "id": "work-and-penalties", "role": "cautions", "title": "How work coverage changes the enrollment decision", "intro": "The useful question is what your present insurance is based on, who pays first, and which enrollment protection it provides.", "items": [ { "label": "Confirm current employment and which insurer pays first", "text": "Coverage based on your or your spouse's current employment may allow a Part B delay with a Special Enrollment Period. Medicare.gov separately asks whether the employer has at least 20 employees for the usual age-65 case. With a smaller employer, the job plan may not pay properly without Medicare A and B. Eligibility for a later signup period does not guarantee that delaying Medicare leaves your medical bills covered today. Ask the benefits administrator and Social Security to identify the coverage basis, payer order, and records needed for the decision.", "source_ids": [ "signup-timing" ] }, { "label": "Use the job-ending date even if COBRA continues", "text": "The current-employment Part B Special Enrollment Period generally ends eight months after the job or group coverage ends, whichever occurs first. COBRA is continued employer-plan coverage after employment changes, but it does not extend this Medicare clock. Retiree coverage also is not current-employment coverage. Medicare.gov explains that waiting for COBRA to expire can therefore leave someone outside the protected window. An eight-month enrollment allowance is not eight months of replacement insurance: request an effective date that coordinates with the end of the insurance actually paying your bills.", "source_ids": [ "signup-timing", "coverage-start" ] }, { "label": "Keep the Part B and Part D penalty clocks separate", "text": "A Part B late-enrollment penalty generally adds 10% for each full 12-month period of an unprotected delay and usually continues while you have Part B. Part D instead looks at time without Part D or creditable prescription coverage after the applicable initial period, including a gap of 63 days or more. Its usual penalty is 1% of the national base beneficiary premium for each uncovered month, not 1% of your chosen plan's price. Extra Help and other protections can change the result. Medicare's penalty guidance establishes these rules; the responsible agency or plan determines an individual's charge.", "source_ids": [ "penalties", "creditable" ] }, { "label": "Check HSA contributions against the Medicare effective date", "text": "An HSA is a Health Savings Account with tax rules tied to eligible insurance coverage. Once Medicare coverage begins, you are no longer eligible to contribute for covered months, including employer contributions. Premium-free Part A obtained after 65 can start retroactively, up to six months before application but not before initial eligibility. The current Medicare & You handbook distinguishes enrolling near 65 from enrolling more than six months later. This is why a blanket 'everyone stops six months before turning 65' instruction is inaccurate. Confirm the retroactive date with Social Security and contribution treatment with a qualified tax adviser before applying.", "source_ids": [ "handbook", "coverage-start", "hsa-question", "working-past-65" ] } ] }, { "id": "coverage-package", "role": "findings", "title": "What changes between Original Medicare and Advantage", "intro": "Compare medical access and protection from costs together. A benefit that looks attractive on paper still needs to work where you receive care.", "items": [ { "label": "Check your clinicians and travel needs for the exact plan", "text": "Original Medicare generally allows care from Medicare-participating providers across the country, whereas Advantage plans often use networks and service areas for ordinary care. A network is the group of providers contracted with the particular plan; a referral is a direction from one clinician to another. Some Advantage plans allow out-of-network care at higher cost, so an insurer's brand or the word PPO does not settle access. Confirm your doctor, hospital, and specialist for the exact plan and year with both the insurer and provider. Ask about ongoing treatment and out-of-area care separately.", "source_ids": [ "compare", "yearly-review" ] }, { "label": "Compare a quiet year and a year with expensive medical care", "text": "Original Medicare alone has no annual ceiling on a person's spending for covered A and B care. Advantage plans have an annual limit for covered Medicare medical services, with plan-specific rules and sometimes different in-network and out-of-network limits. This medical ceiling is separate from the Part D drug limit; premiums and uncovered services need their own budget lines. Medigap can pay some of Original Medicare's remaining covered-service costs, depending on the policy. Compare recurring premiums, routine visits, and plausible hospital or specialist use rather than treating the lowest monthly price as the lowest yearly expense.", "source_ids": [ "costs", "compare", "ma-2026" ] }, { "label": "Check Medigap access before relying on a later switch", "text": "Federal Medigap Open Enrollment is a one-time six-month period beginning the first month you are at least 65 and have Part B. Medicare.gov explains that during this window insurers cannot use medical underwriting to reject you because of health conditions; some pre-existing-condition waiting rules may still matter. Outside it, an insurer may decline coverage or charge more unless a guaranteed-issue protection or state rule applies. Guaranteed issue means a defined right to buy coverage without the usual health-based rejection. Fall plan enrollment does not create that right. Confirm the supplement, drug plan, and effective dates before leaving Advantage.", "source_ids": [ "medigap-ready", "medigap-rights", "fall-enrollment" ] }, { "label": "Give extra benefits a place alongside core care", "text": "Dental, hearing, vision, transportation, or fitness benefits may be useful. Meredith Freed and colleagues' 2026 KFF analysis of CMS plan files shows that advertised supplemental benefits and medical spending limits vary, and some benefits require approval. A benefit category is not a promise of unlimited service: ask about covered procedures, dollar allowances, participating providers, and frequency limits. These extras should be compared with specialist access and medical cost sharing rather than used as a shorthand for the whole plan. National summaries explain common designs; your plan documents establish your particular benefit.", "source_ids": [ "ma-2026" ] } ] }, { "id": "prescription-coverage", "role": "application", "title": "How to compare prescription coverage", "intro": "The useful comparison starts with the medicines you take and where you obtain them, then checks the rules behind the cost estimate.", "items": [ { "label": "Use medicine names, strengths, and pharmacies to compare a year", "text": "A formulary is a plan's list of covered drugs. Plans place drugs in tiers with different cost sharing, and pharmacies may have preferred or standard pricing. Medicare.gov recommends comparing with the actual drug list; enter names, strengths, quantities, and preferred pharmacies rather than rely on a premium or star rating. Save the plan year and exact plan identifier with the estimate. An estimate can change when prescriptions, prices, or pharmacies change, so check the plan's current formulary and written terms before assuming a treatment is covered as expected.", "source_ids": [ "drug-formulary", "drug-costs", "joining-plan" ] }, { "label": "Ask what approval and exception rules mean for your prescription", "text": "Prior authorization means the plan requires approval before covering a drug. Step therapy requires trying a specified lower-cost treatment first; a quantity limit restricts how much the plan will cover over a period. Medicare.gov explains that a prescriber can help request an exception when a restriction is medically inappropriate and supply the required supporting statement. A drug appearing on the list therefore is only the beginning of the coverage check. Ask the plan and prescriber about the particular rule, transition supply, and exception route; this explanation does not decide which medicine you should take.", "source_ids": [ "drug-rules" ] }, { "label": "Keep the drug spending cap distinct from premiums and other care", "text": "For 2026, Medicare lists a $2,100 annual out-of-pocket threshold for covered Part D drugs, after which covered Part D drug cost sharing is zero for the rest of the calendar year. Certain payments made on your behalf can count toward it. This does not cap Part B drugs, uncovered prescriptions, plan premiums, or all medical bills. The threshold changes by year: check the benefit year when comparing. The voluntary Medicare Prescription Payment Plan can spread covered drug payments over remaining months, but it does not lower the total drug cost. Monthly cash flow and total expense answer different questions.", "source_ids": [ "drug-costs", "payment-plan", "payment-fit" ] }, { "label": "Keep proof of creditable coverage even when you take no medicines", "text": "Creditable prescription coverage is insurance expected to pay, on average, at least as much as Part D. Your current insurer must tell you annually whether its drug coverage qualifies. Keep that notice and the coverage dates because a future Part D plan may ask for proof. Drug discount cards and websites are not drug insurance. Medicare.gov also warns that adding Part D can affect existing employer or union coverage for you or dependents, so ask the benefits office before changing it. Being healthy or having no present prescriptions does not determine whether the enrollment rule applies.", "source_ids": [ "creditable", "part-d" ] } ] }, { "id": "what-research-can-tell-you", "role": "findings", "title": "What beneficiary research tells us", "intro": "Research can identify useful questions and problems across Medicare. It cannot enroll you or guarantee what one local plan will do.", "items": [ { "label": "Use satisfaction research to ask about the care you need", "text": "Gretchen Jacobson and colleagues surveyed 3,280 Medicare beneficiaries in English and Spanish from November 2023 through January 2024. About two-thirds in both traditional Medicare and Advantage said coverage fully met their expectations. Advantage respondents more often reported care delays related to getting plan approval; both groups reported access difficulties. This was a weighted observational survey, not random assignment to coverage, and it did not establish that the plan type caused the differences. It supports asking about appointments, authorization, and out-of-pocket costs; it cannot rank your local choices for you.", "source_ids": [ "beneficiary-survey" ] }, { "label": "Ask whether a health comparison accounts for who chose each plan", "text": "Joseph Newhouse, J. Michael McWilliams, and colleagues followed newly enrolled Medicare cohorts in a 2019 study. Advantage enrollees initially had lower adjusted mortality than traditional Medicare enrollees, but the gap narrowed over five years. The abstract identifies a problem with assuming that the groups' starting health differences remain constant. This is a lesson about selection: people choosing different coverage may differ before any plan delivers care. The older observational study does not establish today's best plan; it explains why a lower death rate alone is insufficient evidence that the coverage caused better health.", "source_ids": [ "mortality-study" ] }, { "label": "Use denial research to understand why the appeal route matters", "text": "Jeannie Fuglesten Biniek and colleagues analyzed insurer-level CMS data for 2024 and reported 52.8 million Advantage prior-authorization determinations. About 7.7% were denied fully or partly. Only 11.5% of denied requests were appealed, and 80.7% of those appeals reversed some or all of the original decision. Requests are not unique patients, and appealed cases are a selected subset: an 80.7% reversal figure does not predict your chance of success. The practical lesson is to read the denial's reason and review route rather than assume the first decision is the only available decision.", "source_ids": [ "authorization-study", "rights-help" ] }, { "label": "Separate policy research from a rule already in force", "text": "MedPAC advises Congress on payment, access, and quality. Its reports explain how traditional Medicare pays providers and how Medicare pays private plans; they do not replace enrollment notices. Michael Chernew's payment research helps explain incentives, while the commission's recommendations remain proposals unless implemented through the relevant process. Before using a headline in a coverage decision, identify whether it describes existing rules, a proposed change, or a study. Keep official beneficiary guidance and the exact plan document beside the research rather than letting a national policy debate stand in for your current benefits.", "source_ids": [ "medpac-role", "chernew-profile", "ma-2026" ] }, { "label": "Use the current handbook to answer the complete coverage question", "text": "Medicare & You brings enrollment, covered services, exclusions, appeals, and assistance programs into one reference. The copy available on October 1, 2026 is the 2027 handbook, so its forthcoming-year amounts must not be mistaken for 2026 costs. Use the contents to find your question, then check the current Medicare.gov guidance and the actual insurer document. A handbook explains national rules; it does not list every local plan's drug formulary or replace written confirmation of your own enrollment.", "source_ids": [ "handbook", "drug-formulary" ] } ] }, { "id": "where-judgment-differs", "role": "perspectives", "title": "Where Medicare evidence and policy judgments differ", "intro": "These debates concern what coverage achieves and how Medicare should pay for it. Fixed enrollment deadlines still require the official rule.", "items": [ { "label": "Compare better-care claims with how the groups were studied", "text": "Advantage supporters, including Better Medicare Alliance, argue that coordinated private coverage delivers greater value than traditional Medicare. Beneficiary surveys and observational health studies answer narrower questions. The Commonwealth Fund survey found satisfaction and access difficulties in both arrangements; Newhouse and colleagues showed why changing differences in enrollee health complicate mortality comparisons. The contested judgment is whether observed advantages establish a better coverage system, not whether a person can value a particular benefit. Check the outcome measured and who was compared before treating a broad superiority claim as a finding about your local plan.", "source_ids": [ "bma-payment-response", "beneficiary-survey", "mortality-study" ] }, { "label": "Understand the debate over approval before care", "text": "Prior authorization can check whether requested care meets coverage criteria, while delayed or mistaken decisions can obstruct necessary treatment. CMS is testing WISeR review of selected Original Medicare services in New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington beginning in 2026. KFF's analysis of earlier claims questions how much additional savings this model will produce when payment changes also affect the largest spending category. The disagreement is about the size of the benefit relative to delay and administrative burden, not whether every request should be paid. The model is not national prior authorization for all care, and its goal is not a demonstrated result.", "source_ids": [ "wiser-official", "wiser-analysis" ] }, { "label": "Evaluate extra benefits through their use and their cost", "text": "Better Medicare Alliance argues that spending comparisons miss important value from supplemental benefits and lower patient costs. MedPAC acknowledges that these benefits can help, but questions continued public subsidy growth when their use and value remain incompletely measured. These positions differ about how confidently offered benefits justify additional program spending. A survey of beneficiaries can add information about reported use and limits, while a plan-file analysis describes what is offered; neither alone settles value for everyone. For your own comparison, ask what the needed service covers, who provides it, and what you must pay.", "source_ids": [ "bma-payment-response", "medpac-2026-status", "beneficiary-survey", "ma-2026" ] }, { "label": "Distinguish payment estimates from your own cost comparison", "text": "MedPAC's March 2026 report estimates that Medicare pays more for Advantage enrollees than their care would cost in traditional Medicare, emphasizing differences in who enrolls and how diagnoses are recorded. Better Medicare Alliance challenges the completeness of that comparison, emphasizing differences in benefits and care delivery. This is a disagreement about the comparison method and appropriate public payment, rather than your insurer's premium quote. Neither position proves that a specific local plan is best. Read a national spending estimate as a policy estimate, then compare your actual coverage and costs separately.", "source_ids": [ "medpac-2026-status", "bma-payment-response" ] } ] }, { "id": "keep-coverage-working", "role": "application", "title": "How to keep coverage understandable and usable", "intro": "A small record of dates, notices, contacts, and exact plan details makes later questions easier to resolve.", "items": [ { "label": "Use fall enrollment for the changes it actually permits", "text": "Medicare's fall Open Enrollment runs October 15 through December 7, with plan changes generally effective January 1. For the coming cycle, that means October 15–December 7, 2026 for coverage starting January 1, 2027. It concerns Advantage and drug-plan changes, including moves between Advantage and Original Medicare. It is not a replacement for first enrollment in Part B or a universal Medigap guarantee. The separate January 1–March 31 Advantage Open Enrollment Period is for people already in Advantage; it does not let every Original Medicare enrollee change a standalone drug plan. Special periods depend on qualifying circumstances.", "source_ids": [ "fall-enrollment", "joining-plan" ] }, { "label": "Review the next-year notice and save the exact plan identity", "text": "The Annual Notice of Change describes upcoming plan costs and benefits. Read it with the medicine list, pharmacy, clinicians, and next-year Evidence of Coverage, which sets out benefits and operating rules. Medicare's September 2026 yearly-review publication treats October 1 as preparation for fall enrollment. Staying can preserve familiar care arrangements; switching can improve benefits or costs but require a transition. Compare the written terms before deciding. Keep the exact plan year and identifier, notices, receipts, and effective dates together, with separate medical-enrollment and drug-coverage records. Reviewing can reasonably end in keeping the same plan.", "source_ids": [ "yearly-review", "parts", "creditable" ] }, { "label": "Read an income surcharge notice with its tax year", "text": "IRMAA means Income-Related Monthly Adjustment Amount, an income-based addition to Part B and Part D premiums. SSA's Medicare calculation of modified adjusted gross income adds adjusted gross income and tax-exempt interest. For 2026 it generally uses the 2024 tax return, though older information is sometimes supplied by the IRS. Check which year the notice actually used. Work stoppage or another qualifying life-changing event may justify a new determination using documented information; an amended return has a separate reporting route. A recent income drop alone does not automatically erase the charge. Ask SSA about the process applicable to the notice.", "source_ids": [ "irmaa", "irmaa-review" ] }, { "label": "Ask about help with medical costs and drug costs separately", "text": "Medicare Savings Programs are state-administered assistance with certain A and B costs; which costs are paid depends on the program. States can have eligibility rules more generous than the federal examples, so do not rule yourself out based only on a quick estimate. Extra Help assists with Part D premiums, deductibles, and drug cost sharing. Some people qualify automatically through full-benefit Medicaid, a program paying their Part B premium, or SSI; others apply through Social Security. Medicare and Medicaid can work together. SHIP can help identify current applications and notices; benefit amounts and eligibility limits must be checked for the applicable year and jurisdiction.", "source_ids": [ "savings-programs", "extra-help", "medicaid" ] }, { "label": "Choose assistance with the helper's role in view", "text": "Social Security handles A and B signup and IRMAA; Railroad Retirement beneficiaries may need the Railroad Retirement Board. Medicare answers coverage questions and offers plan comparison, while your insurer handles its plan-specific benefits. The state handles Medicaid and Medicare Savings Programs, and SHIP provides free counseling independent of insurers. A state-licensed broker can explain the plans represented, but ask which insurers are included and how compensation works. Licensing does not prove a comparison includes every available plan. Use the appropriate agency to confirm enrollment; a counseling session or sales call is not itself an A and B application.", "source_ids": [ "ship", "marketing-rules", "ssa-signup", "how-signup" ] }, { "label": "Keep a written record when coverage or a sales promise needs review", "text": "Save the date, exact plan, promised benefit, advertisement, person's name, and any denial notice. A complaint about sales conduct and an appeal of a coverage decision solve different problems. Medicare.gov describes help through the plan, Medicare, SHIP, and the Beneficiary Ombudsman. Ask which review process applies and follow the notice's deadline; a phone discussion does not necessarily stop that clock. For an unexpected solicitation, end the call and use a contact independently obtained from Medicare.gov or your plan card. Official marketing rules prohibit pressure, misleading logos, and other specified sales practices.", "source_ids": [ "rights-help", "marketing-rules" ] } ] }, { "id": "claims-to-check", "role": "cautions", "title": "Check a Medicare claim before acting", "intro": "These examples connect common claims with the rule or evidence needed to assess them. Established means supported; disputed means an unresolved evidence or policy judgment; not means contradicted; talk means a sales or popular saying mistaken for authority.", "items": [ { "label": "Locate your first enrollment period from your birthday", "text": "Claim: The Initial Enrollment Period is usually seven months around age 65. Verdict: established. Confirm the special rule for a first-of-month birthday and distinguish the application window from the coverage start date.", "source_ids": [ "coverage-start" ] }, { "label": "Use coverage rules while you are healthy", "text": "Claim: Feeling healthy lets you ignore Medicare at 65 without a later cost. Verdict: not. Enrollment protection depends on applicable dates and coverage, not current doctor use; an unprotected Part B delay can produce a continuing premium penalty.", "source_ids": [ "penalties", "signup-timing" ] }, { "label": "Compare the complete package for your needs", "text": "Claim: Medicare Advantage is always better than Original Medicare. Verdict: not. The official comparison shows different access and cost arrangements, and Medigap availability must be checked separately.", "source_ids": [ "compare", "medigap-ready" ] }, { "label": "Match prescription coverage to actual medicines", "text": "Claim: Part D should be compared using the drugs you actually take. Verdict: established. The drug list, pharmacy, price, and approval rules make the comparison specific; a headline premium or star rating cannot answer all those questions.", "source_ids": [ "drug-formulary", "drug-rules" ] }, { "label": "Check an income-based premium with Social Security", "text": "Claim: IRMAA can raise Part B and Part D premiums. Verdict: established. SSA determines the adjustment using tax information and provides routes for qualifying events or amended returns.", "source_ids": [ "irmaa", "irmaa-review" ] }, { "label": "Verify the official contact behind a sales message", "text": "Claim: A television ad is the official Medicare enrollment office. Verdict: talk. An ad can market a real plan while remaining a commercial offer. Identify the plan and confirm information through an independent official channel.", "source_ids": [ "marketing-rules", "yearly-review" ] }, { "label": "Keep fall plan changes distinct from Medigap rights", "text": "Claim: Fall Open Enrollment is October 15 to December 7. Verdict: established. Plan changes generally start January 1; this does not create a new universal right to buy Medigap without health-based underwriting.", "source_ids": [ "fall-enrollment", "medigap-ready" ] }, { "label": "Evaluate approval policy by both savings and access", "text": "Claim: Expanding prior authorization is the best way to improve Medicare. Verdict: disputed. It may reduce inappropriate use but may add delays and administrative burden; a model's intended savings do not establish its net effect.", "source_ids": [ "wiser-official", "wiser-analysis" ] } ] }, { "id": "next-step", "role": "next_steps", "title": "Make the next Medicare conversation concrete", "intro": "Start with one page of facts, then use it to check the enrollment route and coverage choices.", "items": [ { "label": "Write the dates and current coverage on one sheet", "text": "Record your birthday month, any A and B effective dates, whether insurance is based on current employment, and when work or coverage ends. Put the official signup window beside the expected coverage start. Use Medicare.gov's questions, then take an uncertain route to Social Security or a SHIP counselor with the notices. The aim is a confirmed calendar, not a plan chosen from memory.", "source_ids": [ "signup-timing", "ship" ] }, { "label": "Try comparing with your actual care list", "text": "Write doctors, hospitals, medicines and strengths, pharmacies, and travel needs. Compare a complete Original Medicare arrangement with the exact Advantage alternative, including premiums and service costs. Save unresolved network, approval, and Medigap questions rather than guess their answers. Medicare's official comparison and plan tool give the structure; the provider, insurer, or counselor can help confirm the details.", "source_ids": [ "yearly-review", "joining-plan" ] }, { "label": "Try checking the transition before submitting the choice", "text": "Ask which agency or plan receives the application, what confirmation to expect, and when each benefit begins. If employment is involved, ask the benefits office about payer order and documentation. If an HSA is involved, check retroactive Part A timing before applying. Keep receipts and notices together and resolve any gap between old and new coverage. For budgeting and accounts, see STUDmoney; Medicare enrollment still belongs with the responsible agency.", "source_ids": [ "ssa-signup", "how-signup", "handbook", "signup-timing" ] } ] }, { "id": "reading-boundaries", "role": "cautions", "title": "Use this reading with official and personal guidance", "items": [ { "label": "Confirm your facts through the responsible enrollment source", "text": "This is a reading companion, not official enrollment, not legal or tax advice, and not an investment pitch. Deadlines and penalties are personal. Use Medicare.gov, Social Security, or a licensed helper for your facts. This page does not sell a plan.", "source_ids": [ "ssa-signup", "ship" ] }, { "label": "Use named teaching as a companion to professional advice", "text": "Named sources. Honest paraphrase of the finding. Not medical, legal, or financial advice.", "source_ids": [ "parts" ] } ] } ], "related": [ "finance", "career", "meaning" ] }, "sources": [ { "id": "parts", "title": "Parts of Medicare", "url": "https://www.medicare.gov/basics/get-started-with-medicare/medicare-basics/parts-of-medicare", "kind": "official", "accessed_at": "2026-10-01", "supports": "A/B/D and Medigap coverage roles.", "limitations": "General categories; exclusions and individual coverage require further checking." }, { "id": "ssa-signup", "title": "Sign up for Medicare", "url": "https://www.ssa.gov/medicare/sign-up", "kind": "official", "accessed_at": "2026-10-01", "supports": "SSA A/B enrollment role, application information and status route.", "limitations": "Not a determination of the reader's personal eligibility; railroad arrangements can differ." }, { "id": "compare", "title": "Compare Original Medicare & Medicare Advantage", "url": "https://www.medicare.gov/basics/get-started-with-medicare/get-more-coverage/your-coverage-options/compare-original-medicare-medicare-advantage", "kind": "official", "accessed_at": "2026-10-01", "supports": "Provider access, medical spending ceilings and alternative coverage packages.", "limitations": "Specific plan network, exclusions and cost sharing vary." }, { "id": "drug-basics", "title": "Drug coverage basics", "url": "https://www.medicare.gov/health-drug-plans/part-d/basics", "kind": "official", "accessed_at": "2026-10-01", "supports": "Separate D plans versus bundled coverage, service area, other coverage coordination.", "limitations": "General coverage routes; not every Advantage plan can combine with a separate D plan." }, { "id": "costs", "title": "Costs", "url": "https://www.medicare.gov/basics/costs/medicare-costs", "kind": "official", "accessed_at": "2026-10-01", "supports": "2026 B costs and distinct medical, drug and Medigap costs.", "limitations": "Amounts have a benefit year; plan costs and income adjustments differ." }, { "id": "cms-2026", "title": "2026 Medicare Parts A & B Premiums and Deductibles", "url": "https://www.cms.gov/newsroom/fact-sheets/2026-medicare-parts-b-premiums-deductibles", "kind": "official", "accessed_at": "2026-10-01", "supports": "2026 standard B premium $202.90 and deductible $283.", "limitations": "These are 2026 amounts, not a forecast of future premiums or an individual quote." }, { "id": "drug-costs", "title": "How much does Medicare drug coverage cost?", "url": "https://www.medicare.gov/health-drug-plans/part-d/basics/costs", "kind": "official", "accessed_at": "2026-10-01", "supports": "Premium, deductible, copay/coinsurance, 2026 $2,100 covered-D threshold and EOB.", "limitations": "Page also includes 2027 amounts; current-year references are explicitly labeled." }, { "id": "coverage-start", "title": "When does Medicare coverage start?", "url": "https://www.medicare.gov/basics/get-started-with-medicare/sign-up/when-does-medicare-coverage-start", "kind": "official", "accessed_at": "2026-10-01", "supports": "IEP, effective-month table, GEP, job SEP and retroactive premium-free A.", "limitations": "Not individualized advice; first-of-month birthdays and exceptional cases have distinct rules." }, { "id": "signup-timing", "title": "When can I sign up for Medicare?", "url": "https://www.medicare.gov/basics/get-started-with-medicare/sign-up/when-can-i-sign-up-for-medicare", "kind": "official", "accessed_at": "2026-10-01", "supports": "Current employment, employer size, payer risks, job loss and deadlines.", "limitations": "Interactive page presents several branches; the prose identifies which usual age-65 branch applies." }, { "id": "how-signup", "title": "How do I sign up for Medicare?", "url": "https://www.medicare.gov/basics/get-started-with-medicare/sign-up/how-do-i-sign-up-for-medicare", "kind": "official", "accessed_at": "2026-10-01", "supports": "Automatic versus application routes, four-month benefits question, notices and RRB.", "limitations": "Automatic B exceptions apply in Puerto Rico/outside U.S.; receiving benefits alone is an incomplete test." }, { "id": "penalties", "title": "Avoid late enrollment penalties", "url": "https://www.medicare.gov/basics/costs/medicare-costs/avoid-penalties", "kind": "official", "accessed_at": "2026-10-01", "supports": "B 10% per full twelve months; D monthly base-premium calculation and 63-day gap.", "limitations": "Exemptions and case determinations matter; examples are not the reader's bill." }, { "id": "creditable", "title": "Creditable prescription drug coverage", "url": "https://www.medicare.gov/health-drug-plans/part-d/basics/creditable-coverage", "kind": "official", "accessed_at": "2026-10-01", "supports": "Definition, yearly notice, proof, discount-card exclusion and employer benefit caution.", "limitations": "D protection is distinct from current-employment B protection." }, { "id": "working-past-65", "title": "Working past 65", "url": "https://www.medicare.gov/basics/get-started-with-medicare/medicare-basics/working-past-65", "kind": "official", "accessed_at": "2026-10-01", "supports": "Job coverage, COBRA distinction and employer/individual HSA contribution caution.", "limitations": "General six-month caution must be read with the actual Part A eligibility/effective date." }, { "id": "handbook", "title": "Medicare & You 2027", "url": "https://www.medicare.gov/publications/10050-medicare-and-you.pdf", "kind": "official", "accessed_at": "2026-10-01", "supports": "Explains HSA timing on printed page 20 and provides an overview of Medicare coverage.", "limitations": "This is the 2027 handbook. Its forthcoming-year amounts must be distinguished from the 2026 costs cited here; only relevant passages informed this article." }, { "id": "medigap-ready", "title": "Get ready to buy", "url": "https://www.medicare.gov/health-drug-plans/medigap/ready-to-buy", "kind": "official", "accessed_at": "2026-10-01", "supports": "One-time six-month Medigap window, underwriting, waiting caveat and guaranteed issue.", "limitations": "Federal baseline; state protections and exact policy benefits differ." }, { "id": "medigap-rights", "title": "When can I buy a Medigap policy?", "url": "https://www.medicare.gov/health-drug-plans/medigap/ready-to-buy/when", "kind": "official", "accessed_at": "2026-10-01", "supports": "State-rights caution and separate protected routes including trial/switch situations.", "limitations": "Branch-specific rights are not universal rights; contact state insurance department." }, { "id": "fall-enrollment", "title": "Open Enrollment", "url": "https://www.medicare.gov/health-drug-plans/open-enrollment", "kind": "official", "accessed_at": "2026-10-01", "supports": "Oct15–Dec7 plan changes, Jan1 effective date, and separate Medigap issue.", "limitations": "Not the general Part B signup window; plan must receive request by deadline." }, { "id": "joining-plan", "title": "Joining a plan", "url": "https://www.medicare.gov/basics/get-started-with-medicare/get-more-coverage/joining-a-plan?linkId=163775130", "kind": "official", "accessed_at": "2026-10-01", "supports": "Plan windows including MA Jan–Mar period and comparing actual medicines.", "limitations": "Special periods and first enrollment vary; not a universal switching right." }, { "id": "yearly-review", "title": "Your Yearly Medicare Review", "url": "https://www.medicare.gov/publications/11220-your-yearly-medicare-review.pdf", "kind": "official", "accessed_at": "2026-10-01", "supports": "September 2026 publication, October 1 preparation, ANOC review, comparison and continuity.", "limitations": "Review is for 2027 benefits; plan-specific confirmation remains necessary." }, { "id": "drug-formulary", "title": "What do drug plans cover?", "url": "https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover", "kind": "official", "accessed_at": "2026-10-01", "supports": "Each plan has its own formulary; coverage questions and pharmacy options.", "limitations": "Actual list and medicine conditions are plan-specific." }, { "id": "drug-rules", "title": "Drug plan rules", "url": "https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules", "kind": "official", "accessed_at": "2026-10-01", "supports": "Prior authorization, step therapy, quantity limits, prescriber exception and transition fill.", "limitations": "No treatment choice or approval promise; page includes a future electronic-process note not treated as active now." }, { "id": "part-d", "title": "What's Medicare drug coverage (Part D)?", "url": "https://www.medicare.gov/health-drug-plans/part-d", "kind": "official", "accessed_at": "2026-10-01", "supports": "D is optional private coverage; taking no drugs does not remove penalty consideration.", "limitations": "Not an individual recommendation for a specific plan." }, { "id": "payment-plan", "title": "What's the Medicare Prescription Payment Plan?", "url": "https://www.medicare.gov/prescription-payment-plan", "kind": "official", "accessed_at": "2026-10-01", "supports": "Voluntary monthly billing option, premiums still owed.", "limitations": "Payment timing is distinct from reduced total cost." }, { "id": "payment-fit", "title": "Will this payment option help me?", "url": "https://www.medicare.gov/prescription-payment-plan/will-this-help-me", "kind": "official", "accessed_at": "2026-10-01", "supports": "Smoothing does not lower costs and bill amounts can vary.", "limitations": "Use examples with personal cash-flow details; not a guarantee of savings." }, { "id": "beneficiary-survey", "title": "What Do Medicare Beneficiaries Value About Their Coverage?", "url": "https://www.commonwealthfund.org/publications/surveys/2024/feb/what-do-medicare-beneficiaries-value-about-their-coverage", "kind": "study", "accessed_at": "2026-10-01", "supports": "Jacobson and colleagues' weighted survey of 3,280 beneficiaries examines satisfaction, access and experiences with supplemental benefits.", "limitations": "2023–24 self-report, observational comparison; cannot establish causal superiority or verify local plan access." }, { "id": "authorization-study", "title": "Medicare Advantage Insurers Made Nearly 53 Million Prior Authorization Determinations in 2024", "url": "https://www.kff.org/medicare/medicare-advantage-insurers-made-nearly-53-million-prior-authorization-determinations-in-2024/", "kind": "study", "accessed_at": "2026-10-01", "supports": "A 2026 analysis of CMS data for 2024: 52.8 million requests; 7.7% denied in whole or part; 11.5% of denials appealed; 80.7% of appeals reversed some or all of the decision.", "limitations": "Insurer-level determinations, not unique patients; selected appeal subset and reporting gaps limit inference." }, { "id": "ma-2026", "title": "Medicare Advantage in 2026: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization", "url": "https://www.kff.org/medicare/medicare-advantage-in-2026-premiums-out-of-pocket-limits-supplemental-benefits-and-prior-authorization/", "kind": "study", "accessed_at": "2026-10-01", "supports": "Freed and colleagues' June 2026 analysis of CMS plan files describes differences in benefits, spending limits, approval requirements and payment design.", "limitations": "National descriptive analysis; exclusions such as employer and special-needs plans affect denominators." }, { "id": "mortality-study", "title": "Adjusted Mortality Rates Are Lower For Medicare Advantage Than Traditional Medicare, But The Rates Converge Over Time", "url": "https://pubmed.ncbi.nlm.nih.gov/30933606/", "kind": "study", "accessed_at": "2026-10-01", "supports": "The abstract of Newhouse and colleagues' 2019 study reports that the initial adjusted mortality difference narrowed over five years, raising questions about how comparisons account for who enrolled.", "limitations": "This account relies on the abstract because full text was unavailable for review. The older cohorts and observational design do not establish a ranking of current local plans." }, { "id": "wiser-official", "title": "WISeR (Wasteful and Inappropriate Service Reduction) Model", "url": "https://www.cms.gov/priorities/innovation/innovation-models/wiser", "kind": "official", "accessed_at": "2026-10-01", "supports": "Selected Original Medicare services in six-state 2026–2031 model and its stated goal.", "limitations": "Model aims are not proof of achieved savings or better care; operational service list can change." }, { "id": "wiser-analysis", "title": "Examining the Potential Impact of Medicare's New WISeR Model", "url": "https://www.kff.org/medicare/examining-the-potential-impact-of-medicares-new-wiser-model/", "kind": "study", "accessed_at": "2026-10-01", "supports": "A 2026 analysis of traditional Medicare claims from 2019–25 distinguishes changes in prices from changes in use and argues that the model's impact may be modest.", "limitations": "Projection from earlier claims, not completed causal evaluation of model; service list has changed." }, { "id": "medpac-role", "title": "What We Do", "url": "https://www.medpac.gov/what-we-do/", "kind": "official", "accessed_at": "2026-10-01", "supports": "Congressional advisory role, public meetings, payment/access/quality reports.", "limitations": "Recommendations are not enrollment decisions or automatically enacted law." }, { "id": "irmaa", "title": "Medicare Premiums", "url": "https://www.ssa.gov/benefits/medicare/medicare-premiums.html", "kind": "official", "accessed_at": "2026-10-01", "supports": "Defines modified adjusted gross income and explains why 2026 premiums generally use the 2024 return, sometimes the 2023 return, and how to seek a correction.", "limitations": "Notice and filing status matter; no personalized tax or investment strategy." }, { "id": "irmaa-review", "title": "Request to lower an Income-Related Monthly Adjustment Amount (IRMAA)", "url": "https://www.ssa.gov/medicare/lower-irmaa", "kind": "official", "accessed_at": "2026-10-01", "supports": "Qualifying income-reducing event request via SSA44 and amended-return route.", "limitations": "SSA must evaluate evidence; lower current income is not automatic removal." }, { "id": "savings-programs", "title": "Medicare Savings Programs", "url": "https://www.medicare.gov/basics/costs/help/medicare-savings-programs", "kind": "official", "accessed_at": "2026-10-01", "supports": "State-administered cost help and state variation beyond federal limits.", "limitations": "Different programs cover different costs; page-year amounts require checking." }, { "id": "extra-help", "title": "Help with drug costs", "url": "https://www.medicare.gov/basics/costs/help/drug-costs", "kind": "official", "accessed_at": "2026-10-01", "supports": "Extra Help scope, automatic qualification pathways, SSA application and MSP linkage.", "limitations": "Territories have other assistance routes; the page combines 2026 eligibility with 2027 benefits, so no generic threshold reproduced." }, { "id": "medicaid", "title": "Medicaid", "url": "https://www.medicare.gov/basics/costs/help/medicaid", "kind": "official", "accessed_at": "2026-10-01", "supports": "Medicare and Medicaid can coexist; state determination.", "limitations": "Eligibility and services vary by state." }, { "id": "ship", "title": "Get help with Medicare enrollment", "url": "https://www.shiphelp.org/what-we-do/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Free independent local counseling, enrollment dates, costs, coordination and appeals.", "limitations": "Counseling is not a final agency eligibility or insurer coverage decision." }, { "id": "rights-help", "title": "Get help with your rights & protections", "url": "https://www.medicare.gov/basics/your-medicare-rights/get-help-with-your-rights-protections", "kind": "official", "accessed_at": "2026-10-01", "supports": "SHIP, Medicare, plan and Ombudsman roles; questions/complaints.", "limitations": "Different appeal and complaint routes have different deadlines; no personalized legal representation." }, { "id": "marketing-rules", "title": "Marketing rules for health plans", "url": "https://www.medicare.gov/health-drug-plans/health-plans/your-coverage-options/plan-marketing-rules", "kind": "official", "accessed_at": "2026-10-01", "supports": "State licensing and prohibited pressure, misleading logos and sales conduct.", "limitations": "Plan marketing rules do not certify every broker covers all options or every complaint's outcome." }, { "id": "hsa-question", "title": "Is the date by which you need to stop HSA contributions always 6-months prior?", "url": "https://www.reddit.com/r/medicare/comments/1mmtfj9/is_the_date_by_which_you_need_to_stop_hsa/", "kind": "question_signal", "accessed_at": "2026-10-01", "supports": "Discussion illustrates questions about retroactive Part A coverage, turning 65 and employer HSA contributions.", "limitations": "Anonymous discussion used only for relevance; handbook/Medicare establish rules." }, { "id": "help-question", "title": "Are there people who can assist in navigating Medicare?", "url": "https://www.reddit.com/r/medicare/comments/xexb1o/are_there_people_who_can_assist_in_navigating/", "kind": "question_signal", "accessed_at": "2026-10-01", "supports": "Discussion illustrates questions about independent counseling and insurance brokers.", "limitations": "Older anecdotal question signal; no claim relies on responses as factual authority." }, { "id": "neuman-profile", "title": "Tricia Neuman — official professional profile", "url": "https://www.kff.org/person/tricia-neuman/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Connects benefits and out-of-pocket costs with program-level Medicare policy.", "limitations": "Her former leadership role provides policy experience; national findings do not establish which local plan suits an individual." }, { "id": "cubanski-profile", "title": "Juliette Cubanski — official professional profile", "url": "https://www.kff.org/person/juliette-cubanski/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Explains Part D policy and beneficiary cost burden, informing separation of premiums and prescription spending.", "limitations": "Policy expertise does not resolve a personal formulary, tax calculation or medical decision." }, { "id": "biniek-profile", "title": "Jeannie Fuglesten Biniek — official professional profile", "url": "https://www.kff.org/person/jeannie-fuglesten-biniek/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Provides insurer-level authorization data and the denominator/appeal-subset distinction.", "limitations": "Determinations are not patients; the national reversal proportion is not an individual's probability." }, { "id": "ochieng-profile", "title": "Nancy Ochieng — official professional profile", "url": "https://www.kff.org/person/nancy-ochieng/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Adds access and financial burden to premium-only comparison.", "limitations": "Research role verified; no local network guarantee or individual eligibility determination." }, { "id": "levitt-profile", "title": "Larry Levitt — official professional profile", "url": "https://www.kff.org/person/larry-levitt/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Clarifies the distinction between coverage policy, plan marketing and administrative questions.", "limitations": "Broader insurance expertise; announced January 2027 leadership role is not treated as current." }, { "id": "freed-profile", "title": "Meredith Freed — official professional profile", "url": "https://www.kff.org/person/meredith-freed/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Connects supplemental-benefit categories with spending limits and authorization conditions.", "limitations": "National plan-file descriptions are not evidence of actual local benefit use." }, { "id": "jacobson-profile", "title": "Gretchen Jacobson — official professional profile", "url": "https://www.commonwealthfund.org/person/gretchen-jacobson", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Her survey compares beneficiaries' expectations, access and experiences with supplemental benefits.", "limitations": "Observational self-report is not random assignment; priorities and confounding limit comparison." }, { "id": "riccardi-profile", "title": "Frederic Riccardi — official professional profile", "url": "https://www.medicarerights.org/staff/frederic-riccardi", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Adds a consumer-navigation perspective to coverage, administrative and appeal questions.", "limitations": "Nonprofit advocacy perspective; agency rules remain authority, no personal legal advice." }, { "id": "stein-profile", "title": "Judith A. Stein — official professional profile", "url": "https://medicareadvocacy.org/judith-stein-jd-executive-director/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Adds coverage-rights and skilled-care advocacy expertise to preserving documentation and review routes.", "limitations": "Her advocacy work explains coverage rights but cannot guarantee the outcome of an individual claim." }, { "id": "lipschutz-profile", "title": "David Lipschutz — official professional profile", "url": "https://medicareadvocacy.org/david-lipschutz-jd-attorney/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Clarifies plan marketing and coverage-policy concerns and the need for the appropriate review route.", "limitations": "Legal advocacy role rather than neutral insurer ranking; no individual legal representation." }, { "id": "edelman-profile", "title": "Toby S. Edelman — official professional profile", "url": "https://medicareadvocacy.org/toby-s-edelman-ed-m-jd-senior-policy-attorney/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Adds a post-acute-care rights perspective when checking hospital and skilled-care coverage.", "limitations": "Nursing-home expertise is narrower than all Medicare enrollment; no personal appeal judgment." }, { "id": "dusetzina-profile", "title": "Stacie B. Dusetzina — official professional profile", "url": "https://www.vumc.org/health-policy/node/957", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Explains why prescription cost burden and access need attention beyond a premium.", "limitations": "Drug-policy research does not choose a medicine or predict an individual's cost or treatment." }, { "id": "upchurch-profile", "title": "Gina Upchurch — official professional profile", "url": "https://www.medpac.gov/member/gina-upchurch/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Connects exact drug lists, benefits counseling and usable community help.", "limitations": "Local program practice does not establish nationwide eligibility or any specific formulary." }, { "id": "konetzka-profile", "title": "R. Tamara Konetzka — official professional profile", "url": "https://www.medpac.gov/member/r-tamara-konetzka/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Studies payment incentives and post-acute/long-term-care quality, broadening focus beyond enrollment ads.", "limitations": "Payment-policy expertise is not personal long-term-care entitlement or a current-plan quality rating." }, { "id": "mcwilliams-profile", "title": "J. Michael McWilliams — official professional profile", "url": "https://hcp.hms.harvard.edu/people/j-michael-mcwilliams", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Coauthored the mortality study discussed here, which illustrates how differences among enrollees complicate comparisons of plan outcomes.", "limitations": "The study is described from its abstract; full text was unavailable for review. Its older findings do not rank 2026 plans." }, { "id": "chernew-profile", "title": "Michael E. Chernew — official professional profile", "url": "https://hcp.hms.harvard.edu/people/michael-e-chernew", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Verified role and public usefulness. Explains benefit designs, Medicare Advantage payments and the incentives created by spending rules.", "limitations": "Past chair tenure is not current chair authority; policy explanation does not settle enrollment or plan selection." }, { "id": "cma-staff", "title": "Personnel & Boards", "url": "https://medicareadvocacy.org/about/staff-biographies/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Current Stein, Lipschutz and Edelman roles checked against official roster.", "limitations": "Role verification, not evidence of an individual's benefits." }, { "id": "cma-webinars", "title": "CMA Webinars", "url": "https://medicareadvocacy.org/webinars/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "Official public Medicare-education program; corroborates public usefulness of advocacy panel.", "limitations": "Program listing, not a claim of viewing recordings or individualized legal advice." }, { "id": "medpac-2026-status", "title": "The Medicare Advantage program: Status report (March 2026 Report to the Congress, Chapter 12)", "url": "https://www.medpac.gov/wp-content/uploads/2026/03/Mar26_Ch12_MedPAC_Report_To_Congress_SEC.pdf", "kind": "official", "accessed_at": "2026-10-01", "supports": "Examines estimated Advantage payments relative to comparable traditional Medicare spending, differences in enrollee health and diagnosis coding, rebate-funded benefits, and gaps in information about benefit use.", "limitations": "These are advisory estimates and policy recommendations, not enacted beneficiary rules. This article draws on relevant passages rather than a review of the entire 130-page chapter." }, { "id": "bma-payment-response", "title": "MedPAC Analysis Highlights Progress, Still Needs to Account for Differences in Medicare Advantage Versus Fee-for-Service", "url": "https://bettermedicarealliance.org/blog-posts/medpac-analysis-highlights-progress/", "kind": "professional", "accessed_at": "2026-10-01", "supports": "January 20, 2026 organizational response explicitly disputes spending-comparison completeness and argues for including supplemental benefits, financial protection and care coordination.", "limitations": "Primary evidence of an MA advocacy organization's position, not independent proof of superior value or a validated replacement spending estimate." } ], "professional_panel": [ { "name": "Tricia Neuman", "credential": "Doctorate in health policy and management; former KFF senior vice president and Medicare program executive director; retired June 2026.", "official_url": "https://www.kff.org/person/tricia-neuman/", "public_usefulness": "Widely cited Medicare policy explanations and congressional testimony; coauthor of opened 2026 MA analyses.", "contribution": "Connects benefits and out-of-pocket costs with program-level Medicare policy.", "boundary": "Her former leadership role provides policy experience; national findings do not establish which local plan suits an individual.", "reviewed_at": "2026-10-01" }, { "name": "Juliette Cubanski", "credential": "PhD in health policy; KFF vice president and director, Program on Medicare Policy.", "official_url": "https://www.kff.org/person/juliette-cubanski/", "public_usefulness": "Public KFF Medicare and prescription-coverage analysis.", "contribution": "Explains Part D policy and beneficiary cost burden, informing separation of premiums and prescription spending.", "boundary": "Policy expertise does not resolve a personal formulary, tax calculation or medical decision.", "reviewed_at": "2026-10-01" }, { "name": "Jeannie Fuglesten Biniek", "credential": "PhD in health policy/health economics; KFF deputy director, Program on Medicare Policy.", "official_url": "https://www.kff.org/person/jeannie-fuglesten-biniek/", "public_usefulness": "Public data analysis and congressional testimony; coauthor of opened prior-authorization research.", "contribution": "Provides insurer-level authorization data and the denominator/appeal-subset distinction.", "boundary": "Determinations are not patients; the national reversal proportion is not an individual's probability.", "reviewed_at": "2026-10-01" }, { "name": "Nancy Ochieng", "credential": "Master's in health policy; KFF senior policy analyst, Program on Medicare Policy.", "official_url": "https://www.kff.org/person/nancy-ochieng/", "public_usefulness": "Public Medicare access and beneficiary financial-burden research; prior CMS payment/quality work.", "contribution": "Adds access and financial burden to premium-only comparison.", "boundary": "Research role verified; no local network guarantee or individual eligibility determination.", "reviewed_at": "2026-10-01" }, { "name": "Larry Levitt", "credential": "Master's in public policy; KFF executive vice president for health policy as of review.", "official_url": "https://www.kff.org/person/larry-levitt/", "public_usefulness": "Longstanding public translation of health insurance and policy.", "contribution": "Clarifies the distinction between coverage policy, plan marketing and administrative questions.", "boundary": "Broader insurance expertise; announced January 2027 leadership role is not treated as current.", "reviewed_at": "2026-10-01" }, { "name": "Meredith Freed", "credential": "Master of Public Policy; KFF senior policy manager, Program on Medicare Policy.", "official_url": "https://www.kff.org/person/meredith-freed/", "public_usefulness": "Coauthor of opened 2026 MA benefit and authorization analyses.", "contribution": "Connects supplemental-benefit categories with spending limits and authorization conditions.", "boundary": "National plan-file descriptions are not evidence of actual local benefit use.", "reviewed_at": "2026-10-01" }, { "name": "Gretchen Jacobson", "credential": "PhD in health economics; Commonwealth Fund vice president and senior scholar, Medicare, Expanding Coverage and Access.", "official_url": "https://www.commonwealthfund.org/person/gretchen-jacobson", "public_usefulness": "Public Medicare surveys, explainers and congressional testimony.", "contribution": "Her survey compares beneficiaries' expectations, access and experiences with supplemental benefits.", "boundary": "Observational self-report is not random assignment; priorities and confounding limit comparison.", "reviewed_at": "2026-10-01" }, { "name": "Frederic Riccardi", "credential": "President, Medicare Rights Center; established Medicare counseling and advocacy leader.", "official_url": "https://www.medicarerights.org/staff/frederic-riccardi", "public_usefulness": "Public Medicare spokesperson, congressional testimony and ombudsman-program work.", "contribution": "Adds a consumer-navigation perspective to coverage, administrative and appeal questions.", "boundary": "Nonprofit advocacy perspective; agency rules remain authority, no personal legal advice.", "reviewed_at": "2026-10-01" }, { "name": "Judith A. Stein", "credential": "JD; founder and senior adviser/attorney, Center for Medicare Advocacy.", "official_url": "https://medicareadvocacy.org/judith-stein-jd-executive-director/", "public_usefulness": "Official biography, current staff directory and public webinar program document beneficiary education.", "contribution": "Adds coverage-rights and skilled-care advocacy expertise to preserving documentation and review routes.", "boundary": "Her advocacy work explains coverage rights but cannot guarantee the outcome of an individual claim.", "reviewed_at": "2026-10-01" }, { "name": "David Lipschutz", "credential": "JD; co-director, Law and Policy/Attorney, Center for Medicare Advocacy.", "official_url": "https://medicareadvocacy.org/david-lipschutz-jd-attorney/", "public_usefulness": "Public Medicare lectures, counselor training, handbook contributions and media explanations.", "contribution": "Clarifies plan marketing and coverage-policy concerns and the need for the appropriate review route.", "boundary": "Legal advocacy role rather than neutral insurer ranking; no individual legal representation.", "reviewed_at": "2026-10-01" }, { "name": "Toby S. Edelman", "credential": "EdM, JD; senior policy attorney, Center for Medicare Advocacy.", "official_url": "https://medicareadvocacy.org/toby-s-edelman-ed-m-jd-senior-policy-attorney/", "public_usefulness": "Training, policy analysis, monthly nursing-home enforcement newsletter and congressional testimony.", "contribution": "Adds a post-acute-care rights perspective when checking hospital and skilled-care coverage.", "boundary": "Nursing-home expertise is narrower than all Medicare enrollment; no personal appeal judgment.", "reviewed_at": "2026-10-01" }, { "name": "Stacie B. Dusetzina", "credential": "PhD; professor of health policy and Ingram Professor of Cancer Research, Vanderbilt University Medical Center.", "official_url": "https://www.vumc.org/health-policy/node/957", "public_usefulness": "Public drug-price explanations and policy research; official page records press engagement and affordability report.", "contribution": "Explains why prescription cost burden and access need attention beyond a premium.", "boundary": "Drug-policy research does not choose a medicine or predict an individual's cost or treatment.", "reviewed_at": "2026-10-01" }, { "name": "Gina Upchurch", "credential": "Registered pharmacist, MPH; founder and executive director, Senior PharmAssist; MedPAC member.", "official_url": "https://www.medpac.gov/member/gina-upchurch/", "public_usefulness": "Medication management, Medicare benefits counseling and community health-literacy work documented in official profile.", "contribution": "Connects exact drug lists, benefits counseling and usable community help.", "boundary": "Local program practice does not establish nationwide eligibility or any specific formulary.", "reviewed_at": "2026-10-01" }, { "name": "R. Tamara Konetzka", "credential": "PhD in health economics; Louis Block Professor of Public Health Sciences, University of Chicago; MedPAC member.", "official_url": "https://www.medpac.gov/member/r-tamara-konetzka/", "public_usefulness": "Public advisory commission work and editorship of Medical Care Research and Review.", "contribution": "Studies payment incentives and post-acute/long-term-care quality, broadening focus beyond enrollment ads.", "boundary": "Payment-policy expertise is not personal long-term-care entitlement or a current-plan quality rating.", "reviewed_at": "2026-10-01" }, { "name": "J. Michael McWilliams", "credential": "MD, PhD; Harvard Medical School professor of health care policy and medicine; practicing general internist, Brigham and Women's Hospital.", "official_url": "https://hcp.hms.harvard.edu/people/j-michael-mcwilliams", "public_usefulness": "Public Medicare research, CMS advisory work and published methods teaching.", "contribution": "Coauthored the mortality study discussed here, which illustrates how differences among enrollees complicate comparisons of plan outcomes.", "boundary": "The study is described from its abstract; full text was unavailable for review. Its older findings do not rank 2026 plans.", "reviewed_at": "2026-10-01" }, { "name": "Michael E. Chernew", "credential": "PhD in economics; Harvard Medical School professor of health care policy and Healthcare Markets and Regulation Lab director; former MedPAC chair 2020–2026.", "official_url": "https://hcp.hms.harvard.edu/people/michael-e-chernew", "public_usefulness": "Official profile links public payment-policy podcasts and congressional testimony.", "contribution": "Explains benefit designs, Medicare Advantage payments and the incentives created by spending rules.", "boundary": "Past chair tenure is not current chair authority; policy explanation does not settle enrollment or plan selection.", "reviewed_at": "2026-10-01" } ] }